Scholarlink

<p><i>Peucedanum japonicum</i> Thunb. (PJ), also known as costal hog fennel, is an edible medicinal plant recognized for its potential health benefits. We previously demonstrated the protective effects of PJ against muscle atrophy in young mice. In the present study, we investigated whether PJ also inhibits age-related muscle loss in aged mice. PJ treatment of primary myoblasts derived from aged mice attenuated myotube diameter reduction, suppressed the expression of atrogenes, and prevented the fast-to-slow myosin heavy chain (MHC) fiber type transition. Additionally, PJ improved mitochondrial respiratory capacity, accompanied by increased PGC1α expression and phosphorylation. Aged mice (20&#xa0;months old) were fed diets supplemented with 0.1% or 0.2% PJ for eight weeks. PJ supplementation enhanced muscle strength and physicalrformance parameters, including treadmill endurance and stride length. Increases in lean body mass, muscle weight, cross-sectional area (CSA), and the ratio of MHCII to MHCI fibers were observed. These improvements were associated with reduced ubiquitin-dependent protein degradation and the downregulation of atrogenes. Furthermore, PJ supplementation promoted mitochondrial activity via PGC1α and stimulated mitochondrial biogenesis through the Nrf1–Tfam pathway. 4-Caffeoylquinic acid (4-CQA), a major bioactive compound in PJ, attenuated myotube atrophy and enhanced mitochondrial respiration in aged myoblasts. These findings suggested that PJ, along with its active compound 4-CQA, has therapeutic potential for combating age-related muscle loss.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Peucedanum japonicum Thunb. ameliorates age-related muscle loss by improving mitochondrial function in aged mice

  • 期刊论文

  • 发表日期：

    2026年2月17日

查看全文
  • Young In Kim,
  • Young-Soo Kim,
  • Chang Hwa Jung,
  • Jiyun Ahn

摘要

Peucedanum japonicum Thunb. (PJ), also known as costal hog fennel, is an edible medicinal plant recognized for its potential health benefits. We previously demonstrated the protective effects of PJ against muscle atrophy in young mice. In the present study, we investigated whether PJ also inhibits age-related muscle loss in aged mice. PJ treatment of primary myoblasts derived from aged mice attenuated myotube diameter reduction, suppressed the expression of atrogenes, and prevented the fast-to-slow myosin heavy chain (MHC) fiber type transition. Additionally, PJ improved mitochondrial respiratory capacity, accompanied by increased PGC1α expression and phosphorylation. Aged mice (20 months old) were fed diets supplemented with 0.1% or 0.2% PJ for eight weeks. PJ supplementation enhanced muscle strength and physicalrformance parameters, including treadmill endurance and stride length. Increases in lean body mass, muscle weight, cross-sectional area (CSA), and the ratio of MHCII to MHCI fibers were observed. These improvements were associated with reduced ubiquitin-dependent protein degradation and the downregulation of atrogenes. Furthermore, PJ supplementation promoted mitochondrial activity via PGC1α and stimulated mitochondrial biogenesis through the Nrf1–Tfam pathway. 4-Caffeoylquinic acid (4-CQA), a major bioactive compound in PJ, attenuated myotube atrophy and enhanced mitochondrial respiration in aged myoblasts. These findings suggested that PJ, along with its active compound 4-CQA, has therapeutic potential for combating age-related muscle loss.